<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ANon-binding_offer_%28NBO%29</id>
	<title>Definition:Non-binding offer (NBO) - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ANon-binding_offer_%28NBO%29"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Non-binding_offer_(NBO)&amp;action=history"/>
	<updated>2026-05-02T22:23:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Non-binding_offer_(NBO)&amp;diff=17733&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Non-binding_offer_(NBO)&amp;diff=17733&amp;oldid=prev"/>
		<updated>2026-03-15T15:36:42Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📝 &amp;#039;&amp;#039;&amp;#039;Non-binding offer (NBO)&amp;#039;&amp;#039;&amp;#039; is a preliminary proposal submitted by a prospective buyer during the early stages of an insurance [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] process, expressing interest in acquiring a target — such as an [[Definition:Insurance carrier | insurance carrier]], [[Definition:Managing general agent (MGA) | MGA]], [[Definition:Insurance broker | brokerage]], or [[Definition:Book of business | book of business]] — along with indicative pricing, key assumptions, and proposed deal structure, without creating a legal obligation to proceed. In insurance transactions, NBOs are a standard feature of structured [[Definition:Auction process | auction processes]] run by investment banks or specialist advisors, allowing the seller to evaluate and compare multiple bidders before granting access to detailed [[Definition:Due diligence | due diligence]] materials.&lt;br /&gt;
&lt;br /&gt;
🔄 The process typically unfolds after bidders have reviewed an [[Definition:Information memorandum (IM) | information memorandum]] or [[Definition:Confidential information memorandum (CIM) | confidential information memorandum]] containing high-level financial data, portfolio characteristics, and strategic positioning. On the basis of that initial information, each bidder submits an NBO that outlines its indicative valuation range — often expressed as a multiple of [[Definition:Embedded value | embedded value]], [[Definition:Book value | book value]], or [[Definition:Earnings before interest, taxes, depreciation, and amortization (EBITDA) | EBITDA]] depending on the type of insurance entity — along with assumptions about [[Definition:Loss reserve | reserve]] adequacy, proposed [[Definition:Transaction structure | transaction structure]] (share deal versus asset deal versus [[Definition:Insurance portfolio transfer (IPT) | portfolio transfer]]), anticipated financing, and key conditions such as [[Definition:Regulatory approval | regulatory approvals]]. The seller&amp;#039;s advisors then shortlist the most credible and attractive NBOs, advancing those bidders to a second round where full [[Definition:Data room | data room]] access, management presentations, and actuarial deep dives become available.&lt;br /&gt;
&lt;br /&gt;
💡 Although the NBO carries no binding commitment, it is far from inconsequential. In insurance M&amp;amp;A, the indicative price and structural clarity of an NBO heavily influence whether a bidder advances — and reputational considerations mean that dramatically re-trading the price in later rounds can damage a buyer&amp;#039;s standing with sell-side advisors and target management. For sellers, the NBO stage serves as an efficient screening mechanism, filtering out bidders that lack the [[Definition:Regulatory capital | capital]], [[Definition:Regulatory approval | regulatory standing]], or strategic rationale to complete the transaction. The transition from NBO to a binding offer typically involves significant additional work, including independent [[Definition:Actuarial review | actuarial reviews]], [[Definition:Reserve study | reserve studies]], and preliminary engagement with insurance regulators, making the NBO a pivotal gateway in the deal timeline.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Non-binding offer letter]]&lt;br /&gt;
* [[Definition:Letter of intent (LOI)]]&lt;br /&gt;
* [[Definition:Information memorandum (IM)]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
* [[Definition:Auction process]]&lt;br /&gt;
* [[Definition:Binding offer]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>